Top news
WHO Director-General commends United States decision to support temporary waiver on intellectual property rights for ...
Stopping Drug Patents Has Stopped Pandemics Before
By Laurie Garrett
Covid-19: Studies Indicate Pfizer-BioNTech Vaccine Protects Against the Most Severe Outcomes of Some Virus ...
By Apoorva Mandavilli, Dan Levin & Thomas Kaplan
Opinion | Patent Busting Won't Help Vaccinate the World Faster
By Scott Gottlieb & Luciana Borio
All coverage
Industry fights over global vaccine patents are just warming up
By Christopher Rowland
Angela Merkel rejects US move to waive patents on vaccines
By Guy Chazan, Hannah Kuchler & Erika Solomon
TRIPS waiver: there's more to the story than vaccine patents
By Hyo Yoon Kang, Siva Thambisetty & Jocelyn Bosse
All you need to know about the battle over COVID jab IP rights
By Virginia Pietromarchi
Explainer: COVID-19 vaccine patents dominate global trade talks
By Philip Blenkinsop
Waiver of patent rights on Covid-19 vaccines, in near term, may be more symbolic than substantive
By Helen Branswell, Matthew Herper & Damian Garde
Explained: Intellectual property waiver for Covid-19 vaccines
By Prabha Raghavan & Aanchal Magazine
Why the TRIPS Waiver Objections Don't Add Up
By Neal Templin
U.S. backs waiving patent protections for Covid vaccines, citing global health crisis
By Thomas Franck, Kevin Breuninger & Amanda Macias
Covid: The vaccine patent row explained
By Dharshini David
Germany rejects U.S. proposal to waive patents on COVID-19 vaccines
By Madeline Chambers, Douglas Busvine & Andreas Rinke
U.S. reverses stance, backs giving poorer countries access to COVID vaccine patents
By Jeff Mason, Andrea Shalal-Esa & David Lawder
Biden Confronts Coronavirus Vaccine Patents
By Thomas Kaplan, Rebecca Robbins & Sheryl Gay Stolberg
Biden administration to waive vaccine patent protection
By Dan Diamond, Tyler Pager & Jeff Stein